PMAQX
Price
$42.63
Change
+$0.74 (+1.77%)
Updated
Apr 11 closing price
Net Assets
27.72B
TCGCX
Price
$17.99
Change
+$0.24 (+1.35%)
Updated
Apr 11 closing price
Net Assets
190.61M
Ad is loading...

PMAQX vs TCGCX

Header iconPMAQX vs TCGCX Comparison
Open Charts PMAQX vs TCGCXBanner chart's image
Principal MidCap R6
Price$42.63
Change+$0.74 (+1.77%)
VolumeN/A
Net Assets27.72B
Thornburg Small/Mid Cap Growth C
Price$17.99
Change+$0.24 (+1.35%)
VolumeN/A
Net Assets190.61M
PMAQX vs TCGCX Comparison Chart
Loading...
View a ticker or compare two or three
VS
PMAQX vs. TCGCX commentary
Apr 12, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PMAQX is a Buy and TCGCX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
PMAQX has more cash in the bank: 27.7B vs. TCGCX (191M). PMAQX pays higher dividends than TCGCX: PMAQX (0.20) vs TCGCX (0.00). PMAQX was incepted earlier than TCGCX: PMAQX (8 years) vs TCGCX (24 years). TCGCX (3.12) is less costly to investors than PMAQX (0.60). TCGCX is a more actively managed with annual turnover of: 57.56 vs. PMAQX (10.50). PMAQX has a lower initial minimum investment than TCGCX: PMAQX (0) vs TCGCX (5000). PMAQX annual gain was more profitable for investors over the last year : 1.93 vs. TCGCX (-14.05). PMAQX return over 5 years is better than : 63.19 vs. TCGCX (-40.03).
PMAQXTCGCXPMAQX / TCGCX
Total Expense Ratio0.602.3426%
Annual Report Gross Expense Ratio0.603.1219%
Fund Existence8 years24 years-
Gain YTD-6.139-19.03732%
Front LoadN/AN/A-
Min. Initial Investment05000-
Min. Initial Investment IRAN/AN/A-
Net Assets27.7B191M14,503%
Annual Yield % from dividends0.200.00-
Returns for 1 year1.93-14.05-14%
Returns for 3 years17.25-7.79-221%
Returns for 5 years63.19-40.03-158%
Returns for 10 yearsN/A-30.22-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TSHA1.250.08
+6.41%
Taysha Gene Therapies
SIDU1.380.08
+6.15%
Sidus Space
XYL109.061.38
+1.28%
Xylem
GB7.380.03
+0.41%
Global Blue Group Holding AG
UMBF86.40-1.74
-1.97%
UMB Financial Corp